Clinical Trial Update: Study of Nevirapine and Prednisone to Determine the Safety and Effectiveness in Preventing Nevirapine Associated Rash in Human Immunodeficiency Virus (HIV) Infected Patients [Phase 4]

View source ↗

Summary

A completed Phase 4 study evaluating whether adding prednisone to nevirapine can prevent nevirapine-associated rash in HIV-infected patients, assessing safety a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PREDNISONE (Prednisone)
• Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 4 | Status: COMPLETED